Interference with islet-specific homing of autoreactive T cells: an emerging therapeutic strategy for type 1 diabetes
- 31 July 2010
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 15 (13-14) , 531-539
- https://doi.org/10.1016/j.drudis.2010.05.013
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Level of major histocompatibility complex class I expression on endothelium in non-obese diabetic mice influences CD8 T cell adhesion and migrationClinical and Experimental Immunology, 2009
- Chapter 18 Matrix Metalloproteinases, T Cell Homing and β‐Cell Mass in Type 1 DiabetesPublished by Elsevier ,2009
- The WAVE2 complex regulates T cell receptor signaling to integrins via Abl- and CrkL–C3G-mediated activation of Rap1The Journal of cell biology, 2008
- Impaired CD4+ and CD8+ T cell phenotype and reduced chemokine secretion in recent-onset type 1 diabetic childrenClinical and Experimental Immunology, 2008
- The CXCR4/CXCL12 (SDF-1) signalling pathway protects non-obese diabetic mouse from autoimmune diabetesClinical and Experimental Immunology, 2007
- Mechanistic insights into targeting T cell membrane proteinase to promote islet β‐cell rejuvenation in type 1 diabetesThe FASEB Journal, 2006
- Transient Chemokine Receptor Blockade does not Prevent, but may Accelerate Type 1 Diabetes in Prediabetic NOD MiceHormone and Metabolic Research, 2006
- Genetic analysis of integrin activation in T lymphocytesImmunological Reviews, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Rap1 signalling: adhering to new modelsNature Reviews Molecular Cell Biology, 2001